SCHEMBL8929781

SCHEMBL8929781

CC(C)OC(=O)Nc1ccc(Cl)c(C(=O)OC(C)C)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.58
ALOX15 P16050 1/20 0.58
KDM4E B2RXH2 2/20 0.56
LMNA P02545 5/20 0.54
HTT P42858 3/20 0.54
SMN1; SMN2 Q16637 4/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
NPC1 O15118 1/20 0.51
CYP2D6 P10635 1/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 6/20 0.51
MEN1 O00255 5/20 0.51
MAPT P10636 4/20 0.49
NPSR1 Q6W5P4 1/20 0.49
AGPAT2 O15120 1/20 0.48
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
RORC P51449 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27344589 0.88 HPGD (0.58) HPGDALOX15KDM4ELMNAHTT
SCHEMBL24269573 0.88 LMNA (0.46) HPGDALOX15KDM4ELMNAHTT
SCHEMBL6362855 0.87 LMNA (0.50) HPGDALOX15KDM4ELMNAHTT
SCHEMBL9198195 0.86 LMNA (0.49) HPGDALOX15KDM4ELMNAHTT
SCHEMBL6362857 0.86 LMNA (0.52) KDM4ELMNAHTTSMN1; SMN2CYP2C9
SCHEMBL24308304 0.85 LMNA (0.49) KDM4ELMNAHTTSMN1; SMN2NPC1
SCHEMBL10608407 0.84 HTT (0.71) HPGDALOX15KDM4ELMNAHTT
SCHEMBL9196939 0.84 SMN1; SMN2 (0.61) HPGDKDM4ELMNAHTTSMN1; SMN2
SCHEMBL8930021 0.83 ALDH1A1 (0.47) KDM4ELMNAHTTSMN1; SMN2CYP1A2
SCHEMBL9198085 0.83 SMN1; SMN2 (0.67) KDM4ELMNAHTTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP claimed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP claimed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO claimed
US-5693827-A Treatment of HIV infections and compounds useful therein UNIROYAL CHEMICAL COMPANY, INC. 1997-12-02 US disclosed
EP-0497816-B1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD (CA) 1995-05-17 EP disclosed
US-5268389-A Containing a benzene ring UNIROYAL CHEMICAL COMPANY, INC. (US) 1993-12-07 US disclosed
EP-0497816-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN. UNIROYAL CHEMICAL LTD (CA) 1992-08-12 EP disclosed
WO-1991005761-A1 TREATMENT OF HIV INFECTIONS AND COMPOUNDS USEFUL THEREIN UNIROYAL CHEMICAL LTD./UNIROYAL CHEMICAL LTEE (CA) 1991-05-02 WO disclosed
CN-1051036-A The treatment of HIV (human immunodeficiency virus) infections and in treatment used compound UNIROYAL CHEM CO INC (US) 1991-05-01 CN disclosed